Literature DB >> 30298341

Driveline angle is crucial for preventing driveline infection in patients with HeartMate II device.

Yorihiko Matsumoto1,2, Satsuki Fukushima1, Yusuke Shimahara1, Kizuku Yamashita1, Naonori Kawamoto1, Kensuke Kuroda3, Osamu Seguchi3, Masanobu Yanase3, Norihide Fukushima3, Hideyuki Shimizu2, Junjiro Kobayashi1,2, Tomoyuki Fujita4.   

Abstract

We hypothesized that the externalizing direction of the driveline (the driveline angle) at the percutaneous exit site would influence the occurrence of driveline infection after left ventricular assist device implantation. From August 2013 to May 2017, 71 patients were implanted with a HeartMate II device in our center. The driveline angle was measured on anteroposterior radiography just after implantation. Risk factors for driveline infection were analyzed by uni- and multivariate analyses. Driveline infection developed in 10 (14%) patients during follow-up. Overall actual freedoms from driveline infection at 6, 12, and 24 months were 96%, 88%, and 86%, respectively. Overall number of driveline infection events per patient-year was 0.16. Receiver operating characteristic analysis determined the cut-off point of the driveline angle as 41°. The 6-, 12-, and 24-month actuarial freedoms from driveline infection in those with driveline angle more than 42° (84%, 74%, and 74%, respectively) were significantly lower than in those with driveline angle less than 41° (97%, 94%, and 90%, respectively; p < 0.02). The numbers of driveline infection events per patient-year were 0.16 in patients with driveline angle more than 42°, and 0.04 in patients with driveline angle less than 41°. Multivariate analysis demonstrated that driveline angle more than 42° was an independent risk factor for driveline infection (hazard ratio 4.71). Driveline angle more than 42° is an independent risk factor for driveline infection in patients with HeartMate II. Externalization of the driveline toward the horizontal direction is important to prevent driveline infection with HeartMate II.

Entities:  

Keywords:  Driveline infection; HeartMate II; Implant procedure; Implantable LVAD; Prevention

Mesh:

Year:  2018        PMID: 30298341     DOI: 10.1007/s10047-018-1074-x

Source DB:  PubMed          Journal:  J Artif Organs        ISSN: 1434-7229            Impact factor:   1.731


  4 in total

Review 1.  Journal of Artificial Organs 2019: the year in review : Journal of Artificial Organs Editorial Committee.

Authors:  Y Sawa; G Matsumiya; S Miyagawa; E Tatsumi; T Abe; K Fukunaga; S Ichiba; T Taguchi; K Kokubo; T Masuzawa; A Myoui; M Nishimura; T Nishimura; T Nishinaka; E Okamoto; S Tokunaga; T Tomo; T Tsukiya; Y Yagi; T Yamaoka
Journal:  J Artif Organs       Date:  2020-02-19       Impact factor: 1.731

Review 2.  Non-patient factors associated with infections in LVAD recipients: A scoping review.

Authors:  Supriya Shore; Michael J Pienta; Tessa M F Watt; Gardner Yost; Whitney A Townsend; Lourdes Cabrera; Michael D Fetters; Carol Chenoweth; Keith D Aaronson; Francis D Pagani; Donald S Likosky
Journal:  J Heart Lung Transplant       Date:  2021-10-22       Impact factor: 13.569

Review 3.  Ventricular Assist Device-Specific Infections.

Authors:  Yue Qu; Anton Y Peleg; David McGiffin
Journal:  J Clin Med       Date:  2021-01-25       Impact factor: 4.241

4.  Driveline Features as Risk Factor for Infection in Left Ventricular Assist Devices: Meta-Analysis and Experimental Tests.

Authors:  Melanie Kranzl; Martin Stoiber; Anne-Kristin Schaefer; Julia Riebandt; Dominik Wiedemann; Christiane Marko; Günther Laufer; Daniel Zimpfer; Heinrich Schima; Thomas Schlöglhofer
Journal:  Front Cardiovasc Med       Date:  2021-12-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.